|
[1]FAN JG, FARRELL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol, 2009, 50 (1) :204-210.
|
|
[2]de ALWIS NM, DAY CP.Non-alcoholic fatty liver disease:the mist gradually clears[J].J Hepatol, 2008, 48 (Suppl 1) :s104-s112.
|
|
[3]HAN TQ, JIANG ZY, ZHANG SD.Pathogenesis of the cholesterol stone formation[J].J Surg Concepts Pract, 2009, 14 (2) :125-127. (in Chinese) 韩天权, 蒋兆彦, 张圣道.胆固醇结石形成机制的基因研究现状与展望[J].外科理论与实践, 2009, 14 (2) :125-127.
|
|
[4]RAMOS-DE LA MEDINA A, REMES-TROCHE JM, ROESCH-DIETLEN FB, et al.Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease:is it justified?[J].J Gastrointest Surg, 2008, 12 (12) :2097-2102.
|
|
[5]ROESCH-DIETLEN F, PREZ-MORALES A, MELO-SANTISTEBAN G, et al.Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease[J].Cir Cir, 2008, 76 (1) :37-42.
|
|
[6]MNDEZ-SNCHEZ N, BERMEJO-MARTNEZ LB, VINˇALS Y, et al.Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects[J].World J Gastroenterol, 2005, 11 (39) :6182-6187.
|
|
[7] TARGHER G, DAY CP, BONORA E.Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J].N Engl J Med, 2010, 363 (14) :1341-1350.
|
|
[8]OLAIYA MT, CHIOU HY, JENG JS, et al.Significantly increased risk of cardiovascular disease among patients with gallstone disease:a population-based cohort study[J].PLoS One, 2013, 8 (10) :e76448.
|
|
[9]DAY CP.Pathogenesis of steatohepatitis[J].Best Prac Res Clin Gastroenterol, 2002, 16 (5) :663-678.
|
|
[10]TAMURA S, SHIMOMURA I.Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease[J].J Clin Invest, 2005, 115 (5) :1139-1142.
|
|
[11]CHANG Y, SUNG E, RYU S, et al.Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men[J].J Korean Med Sci, 2008, 23 (4) :644-650.
|
|
[12]BIDDINGER SB, HAAS JT, YU BB, et al.Hepatic insulin resistance directly promotes formation of cholesterol gallstones[J].Nat Med, 2008, 14 (7) :778-782.
|
|
[13]GURAYA SY.Reappraisal of the management of cholelithiasis in diabetics[J].Saudi Med J, 2005, 26 (11) :1691-1694.
|
|
[14]TSAI CJ, LEITZMANN MF, WILLETT WC, et al.Macronutrients and insulin resistance in cholesterol gallstone disease[J].Am J Gastroenterol, 2008, 103 (11) :2932-2939.
|
|
[15]XIE Y, NEWBERRY EP, KENNEDY SM, et al.Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice[J].J Lipid Res, 2009, 50:977-987.
|
|
[16]CHATRATH H, VUPPALANCHI R, CHALASANI N.Dyslipidemia in patients with nonalcoholic fatty liver disease[J].Semin Liver Dis, 2012, 32 (1) :22-29.
|
|
[17]SPELIOTES EK, MASSARO JM, HOFFMANU U, et al.Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat:the framingham heart study[J].Hepatology, 2010, 51 (6) :1979-1987.
|
|
[18]ASSY N, KAITA K, MYMIN D, et al.Fatty infiltration of liver in hyperlipidemic patients[J].Dig Dis Sci, 2000, 45 (10) :1929-1934.
|
|
[19]PORTINCASA P, DI CIAULA A, WANG HH, et al.Coordinate regulation of gallbladder motor function in the gut-liver axis[J].Hepatology, 2008, 47 (6) :2112-2126.
|
|
[20]WANG DQ, COHEN DE, CAREY MC.Biliary lipids and cholesterol gallstone disease[J].J Lipid Res, 2009, 50 (Suppl) :s406-s411.
|
|
[21]LIEW PL, LEE WJ, WANG W, et al.Fatty liver disease:predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity[J].Obesity Surgery, 2008, 18 (7) :847-848.
|
|
[22]LORIA P, LONARDO A, LOMBARDINI S, et al.Gallstone disease in nonalcoholic fatty liver:prevalence and associated factors[J].J Gastroenterol Hepatol, 2005, 20 (8) :1176-1184.
|
|
[23]YU L, HE XD, WU Q, et al.The risk factor of gallstones[J].Chin J Hepatobiliary Surg, 2011, 17 (9) :711-713. (in Chinese) 于岚, 何小东, 武峤, 等.胆囊结石相关危险因素的探讨[J].中华肝胆外科杂志, 2011, 17 (9) :711-713.
|
|
[24]FAN Y, WU SD, FU BB.Effect of intestinal transit on the formation of cholesterol gallstones in hamsters[J].Hepatobiliary Pancreat Dis Int, 2007, 6 (5) :513-515.
|
|
[25]WANG HH, WANG DQ.Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine[J].Hepatology, 2005, 42 (4) :894-904.
|
|
[26]MACHADO M, MARQUES-VIDAL P, CORTEZ-PINTO H.Hepatic histology in patients undergoing bariatric surgery[J].J Hepatol, 2006, 45 (4) :600-606.
|
|
[27] VERNON G, BARANOVA A, YOUNOSSI ZM.Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther, 2011, 34 (3) :274–285.
|
|
[28]WANLESS IR, LENTZ JS.Fatty liver hepatitis (steatohepatitis) and obesity:an autopsy study with analysis of risk factors[J].Hepatology, 1990, 12 (5) :1106-1110.
|
|
[29]MOHAMMAD H, ABO-RYIA, HAMDY S, et al.Predictors of gallstone formation in morbidly obese patients after bariatric surgery:A retrospective observational study[J].Surgical Science, 2014, 5:1-5.
|
|
[30]HATZIAGELAKI E, KARAGEORGOPOULOS DE, CHOUNTA A, et al.Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease[J].Exp Diabetes Res, 2012, 2012:351974.
|
|
[31]CHEN GY, FAN JG.Advances in epidemiological study of fatty liver disease in China[J].Chin J Pract Intern Med, 2013, 33 (9) :738-741. (in Chinese) 陈光输, 范建高.中国脂肪性肝病流行病学研究进展[J].中国实用内科杂志, 2013, 33 (9) :738-741.
|
|
[32]ADAMS LA, WATERS OR, KNUIMAN MW, et al.NAFLD as a risk factor for the development of diabetes and the metabolic syndrome:an eleven-year follow-up study[J].Am J Gastroenterol, 2009, 104 (4) :861-867.
|
|
[33]SHIBATA M, KIHARA Y, TAGUCHI M, et al.Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men[J].Diabetes Care, 2007, 30 (11) :2940-2944.
|
|
[34]WILLIAMSON RM, PRICE JF, GLANCY S, et al.Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes:the edinburgh type 2 diabetes study[J].Diabetes Care, 2011, 34 (5) :1139-1144.
|
|
[35]TOLMAN KG, FONSECA V, TAN MH, et al.Narrative review:hepatobiliary disease in type 2 diabetes mellitus[J].Ann Intern Med, 2004, 141 (12) :946-956.
|
|
[36]MAWE G.Nerves and hormones interact to control gallbladder function[J].News Physiol Sci, 1998, 13 (1) :84-90.
|
|
[37]MOLLESTON J, WHITE F, TECKMAN J, et al.Obese children with steatohepatitis can develop cirrhosis in childhood[J].Am J Gastroenterol, 2002, 97 (9) :2460-2462.
|
|
[38]FAN JG, CHEN L, ZHU J, et al.The epidemiology investigation of the relationship between fatty liver and gallstones disease[J].Clin J Gastroeaterol, 2005, 10 (2) :110-112. (in Chinese) 范建高, 陈兰, 朱军, 等.脂肪肝与胆石症关系的流行病学调查[J].胃肠病学, 2005, 10 (2) :110-112.
|
|
[39]PILZ S, MANGGE H, OBERMAYER-PIETSCH B, et al.Visfatin/pre-B-cell colony-enhancing factor:a protein with various suggested functions[J].J Endocrinol Invest, 2007, 30 (2) :138-144.
|
|
[40]KONG XS, KONG X, MO HY, et al.The epidemological investigation and analysis of gallstones in different occupations[J].Chin J Epidemiology, 2000, 21 (10) :395. (in Chinese) 孔祥森, 孔鑫, 莫惠英, 等.不同职业人群胆结石流行病学调查分析[J].中华流行病学, 2000, 21 (10) :395.
|
|
[41]CHEN LY, QIAO QH, ZHANG SC, et al.Metabolic syndrome and gallstone disease[J].World J Gastroenterol, 2012, 18 (31) :4215-4220.
|
|
[42]ZHANG Y, LIU D, MA Q, et al.Factors influencing the prevalence of gallstones in liver cirrhosis[J].J Gastroenterol Hepatol, 2006, 21 (9) :1455-1458.
|
|
[43] BELLENTANI S, SACCOCCIO G, MASUTTI F, et al.Prevalence of and risk factors for hepatic steatosis in Northern Italy[J].Ann Intern Med, 2000, 132 (2) :112-117.
|
|
[44]IOANNOU GN.Cholelithiasis, cholecystectomy, and liver disease[J].Am J Gastroenterol, 2010, 105 (6) :1364-1373.
|
|
[45]JIA YL, FAN DP.The relation between recessive gallstones and liver damage[J].J Cap Med Univ, 2000, 21 (1) :49-50. (in Chinese) 贾玉龙, 范东坡.隐性胆囊结石与肝脏损害的关系[J].首都医科大学学报, 2000, 21 (1) :49-50.
|
|
[46]FRACANZANI AL, VALENTI L, RUSSELLO M, et al.Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease[J].PLoS One, 2012, 7 (7) :e41183.
|
|
[47]FRACANZANI AL, VALENTI L, BUGIANESI E, et al.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels:A role for insulin resistance and diabetes[J].Hepatology, 2008, 48 (3) :792-798.
|
DownLoad: